Clinical Trials for Epithelial Ovarian Cancer

Find clinical trials for epithelial ovarian cancer. Discover research opportunities and treatment options in your area.

51 Active Trials Found

Showing 51 trials on this page

Page 1 of 3

CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.

NCT ID: NCT06690775

The CATALINA-2 clinical trial is researching a new treatment called TORL-1-23 for women with advanced ovarian cancer that has not responded to platinum-based chemotherapy. This study is focused on ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Minneapolis, Minnesota, United States, Duarte, California, United States +22 more

A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

NCT ID: NCT06890338

This clinical trial is designed to evaluate the safety and effectiveness of a combination treatment using two drugs, carboplatin and mirvetuximab soravtansine (often called MIRV), for women with ad...

Not yet recruiting

Phase: PHASE2 Type: interventional

Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer

NCT ID: NCT06915025

This clinical trial is studying a new treatment called IMNN-001, which will be given directly into the abdomen along with standard chemotherapy for women who have been newly diagnosed with advanced...

Not yet recruiting

Phase: PHASE3 Type: interventional

Study of AVZO-021 in Patients With Advanced Solid Tumors

NCT ID: NCT05867251

This clinical trial is studying a new oral medication called AVZO-021, which is designed to treat patients with advanced solid tumors. The main goals of the study are to understand how safe the med...

Recruiting

Phase: PHASE1 Type: interventional Locations: Tampa, Florida, United States, Sarasota, Florida, United States +8 more

A Study Comparing BL-B01D1 With the Investigator's Choice of Chemotherapy in Patients With Platinum-resistant Recurrent Epithelial Ovarian Cancer

NCT ID: NCT06994195

This clinical trial is studying a new treatment called BL-B01D1 for patients with certain types of recurrent ovarian cancer that do not respond to platinum-based chemotherapy. The trial aims to see...

Not yet recruiting

Phase: PHASE3 Type: interventional Locations: Shanghai, Shanghai, China

CT-95 in Advanced Cancers Associated With Mesothelin Expression

NCT ID: NCT06756035

This clinical trial is studying a new treatment called CT-95 for patients with advanced cancers that express a protein called mesothelin. Mesothelin is found in certain types of tumors, including a...

Recruiting

Phase: PHASE1 Type: interventional Locations: San Antonio, Texas, United States, Hackensack, New Jersey, United States

A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE)

NCT ID: NCT05429970

The PRESERVE clinical trial is exploring whether a combination of medications, specifically propranolol and etodolac, along with mind-body resilience training and music therapy, can help reduce str...

Recruiting

Phase: NA Type: interventional Locations: New York, New York, United States, Basking Ridge, New Jersey, United States +7 more

A Study to Learn if 27T51, a Mucin-16 (MUC16) Protein Targeting Immune Cell Therapy, Administered Alone or in Combination is Safe and How Well it Works for Adult Participants With Recurrent or Treatment Resistant Ovarian Cancers

NCT ID: NCT06469281

This clinical trial is studying a new treatment called 27T51, which is a type of immune cell therapy designed to help fight certain types of ovarian cancer, including epithelial ovarian cancer, pri...

Recruiting

Phase: PHASE1 Type: interventional Locations: Boston, Massachusetts, United States, Pittsburgh, Pennsylvania, United States +3 more

Prehabilitation for EOC, Fallopian Tube, Primary Peritoneal Carcinoma and Pancreatic Cancer w/ NACT

NCT ID: NCT06412510

This clinical trial is studying a program designed to help patients prepare for cancer surgery. It focuses on whether an exercise and nutrition plan can help people with advanced ovarian cancer or ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Cleveland, Ohio, United States

Tinzaparin And Biomarkers After Neoadjuvant Treatment of Ovarian Cancer

NCT ID: NCT05284552

This clinical trial is studying the effects of a medication called tinzaparin, which is typically used to prevent blood clots, in women with advanced epithelial ovarian cancer who are receiving che...

Recruiting

Phase: PHASE2 Type: interventional Locations: Linköping, östergötland, Sweden, Eksjö, , Sweden +8 more

WoO: Window of Opportunity Trial of Olaparib and Durvalumab in Histologically Proven EOC

NCT ID: NCT04644289

The Window of Opportunity Trial is studying the effects of two medications, Olaparib and Durvalumab, on women with advanced epithelial ovarian cancer (EOC). This clinical trial aims to understand h...

Recruiting

Phase: PHASE2 Type: interventional Locations: Mannheim, Baden Württemberg, Germany, Essen, North Rine Westphalia, Germany +5 more

CRS & HIPEC for Platinum-Resistant Recurrent Ovarian Cancer (KOV-02R, RECOVER)

NCT ID: NCT05316181

This clinical trial is studying a new treatment approach for women with recurrent ovarian cancer that has not responded to standard platinum-based chemotherapy. The trial is testing whether adding ...

Recruiting

Phase: PHASE3 Type: interventional Locations: Seoul, , Korea, Republic Of, Seoul, , Korea, Republic Of +1 more

Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors

NCT ID: NCT04429542

This clinical trial is studying a new experimental drug called BCA101 to see how safe it is and how well it works on patients with certain types of advanced cancers that are driven by a protein cal...

Recruiting

Phase: PHASE1 Type: interventional Locations: Providence, Rhode Island, United States, Heidelberg, Victoria, Australia +18 more

Fasting During Neoadjuvant Chemotherapy in Patient With Epithelial Ovarian Cancer

NCT ID: NCT06386887

This clinical trial is looking at whether timed fasting—where you don't eat for certain hours each day—can be safely used by women with epithelial ovarian cancer who are undergoing chemotherapy bef...

Recruiting

Phase: NA Type: interventional Locations: Cleveland, Ohio, United States

NEOadjuvant Dendritic Cell Vaccination for Ovarian Cancer

NCT ID: NCT05773859

This clinical trial is exploring a new treatment for women with a specific type of ovarian cancer called high-grade serous epithelial ovarian cancer. The goal is to see if a special vaccine, made f...

Recruiting

Phase: PHASE1 Type: interventional Locations: Nijmegen, Gelderland, Netherlands

EPITOME-1015-I: a Study to Investigate the Safety and Tolerability of MDG1015 in Patients with Epithelial Ovarian Cancer, Gastroesophageal Adenocarcinoma, Round Cell Liposarcoma And/or Synovial Sarcoma

NCT ID: NCT06748872

The EPITOME-1015-I clinical trial is investigating a new treatment called MDG1015 for patients with certain types of cancer, including epithelial ovarian cancer, gastroesophageal adenocarcinoma, an...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: Seattle, Washington, United States

Prognostic and Diagnostic Added Value of Medical Imaging in Gynecological Cancer (PRODIGYN)

NCT ID: NCT05855941

The PRODIGYN trial is a study that aims to understand how advanced medical imaging can help doctors better diagnose and treat women with cervical, endometrial, and ovarian cancers. Specifically, th...

Recruiting

Type: observational Locations: Umea, , Sweden

T-regulatory Cell Depletion with E7777 Combined with Pembrolizumab in Recurrent or Metastatic Solid Tumors

NCT ID: NCT05200559

This clinical trial is investigating a new treatment approach for women with recurrent or metastatic epithelial ovarian cancer, a type of cancer that can be very difficult to treat. The study is lo...

Recruiting

Phase: PHASE1 Type: interventional Locations: Pittsburgh, Pennsylvania, United States

Surgery for Ovarian Cancer After PARPi Therapy in Precision

NCT ID: NCT06602063

This clinical trial is exploring a new treatment approach for women with certain types of ovarian cancer that have come back after initial treatment. Specifically, it looks at whether surgery to re...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: Shanghai, , China, Wuhan, , China

A Study of ZN-c3 in Patients With Ovarian Cancer

NCT ID: NCT04516447

This clinical trial is looking at a new treatment called ZN-c3 for women with advanced ovarian cancer, fallopian tube cancer, or peritoneal cancer. It's a Phase 1 study, which means it's one of the...

Recruiting

Phase: PHASE1 Type: interventional Locations: Houston, Texas, United States, Boston, Massachusetts, United States +22 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions